BOSTON — In patients with postinfarction ventricular septal defects, percutaneous and surgical treatments reduced mortality rates compared with historical medical therapy data, researchers reported at TCT 2022.The percutaneous and surgical strategies for postinfarction ventricular septal defects (VSD) did not differ significantly from each other in all-cause mortality at 5 years, but the